Sol Efroni
Cited by
Cited by
Global transcription in pluripotent embryonic stem cells
S Efroni, R Duttagupta, J Cheng, H Dehghani, DJ Hoeppner, C Dash, ...
Cell stem cell 2 (5), 437-447, 2008
IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39
ID Mascanfroni, A Yeste, SM Vieira, EJ Burns, B Patel, I Sloma, Y Wu, ...
Nature immunology 14 (10), 1054-1063, 2013
Rep‐Seq: uncovering the immunological repertoire through next‐generation sequencing
J Benichou, R Ben‐Hamo, Y Louzoun, S Efroni
Immunology 135 (3), 183-191, 2012
Toward rigorous comprehension of biological complexity: modeling, execution, and visualization of thymic T-cell maturation
S Efroni, D Harel, IR Cohen
Genome research 13 (11), 2485-2497, 2003
The linker histone H1. 0 generates epigenetic and functional intratumor heterogeneity
CM Torres, A Biran, MJ Burney, H Patel, T Henser-Brownhill, AHS Cohen, ...
Science 353 (6307), aaf1644, 2016
Identification of key processes underlying cancer phenotypes using biologic pathway analysis
S Efroni, CF Schaefer, KH Buetow
PloS one 2 (5), e425, 2007
Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma
RJ Clifford, J Zhang, DM Meerzaman, MS Lyu, Y Hu, CM Cultraro, ...
Hepatology 52 (6), 2034-2043, 2010
Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge
AL Tarca, M Lauria, M Unger, E Bilal, S Boue, K Kumar Dey, J Hoeng, ...
Bioinformatics 29 (22), 2892-2899, 2013
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
Y Zhu, Y Liu, C Zhang, J Chu, Y Wu, Y Li, J Liu, Q Li, S Li, Q Shi, L Jin, ...
Nature communications 9 (1), 1595, 2018
Reactive animation: Realistic modeling of complex dynamic systems
S Efroni, D Harel, IR Cohen
Computer 38 (1), 38-47, 2005
Using cellular automata modeling of the emergence of innovations
J Goldenberg, S Efroni
Technological Forecasting and Social Change 68 (3), 293-308, 2001
Emergent dynamics of thymocyte development and lineage determination
S Efroni, D Harel, IR Cohen
PLoS computational biology 3 (1), e13, 2007
Altered immune pathway activity under exercise challenge in Gulf War Illness: an exploratory analysis
G Broderick, R Ben-Hamo, S Vashishtha, S Efroni, L Nathanson, Z Barnes, ...
Brain, behavior, and immunity 28, 159-169, 2013
Reciprocal regulation between SIRT6 and miR-122 controls liver metabolism and predicts hepatocarcinoma prognosis
S Elhanati, R Ben-Hamo, Y Kanfi, A Varvak, R Glazz, B Lerrer, S Efroni, ...
Cell reports 14 (2), 234-242, 2016
Fmrp interacts with adar and regulates RNA editing, synaptic density and locomotor activity in zebrafish
A Shamay-Ramot, K Khermesh, HT Porath, M Barak, Y Pinto, C Wachtel, ...
PLoS genetics 11 (12), e1005702, 2015
Predicting and affecting response to cancer therapy based on pathway-level biomarkers
R Ben-Hamo, A Jacob Berger, N Gavert, M Miller, G Pines, R Oren, ...
Nature communications 11 (1), 3296, 2020
MicroRNA regulation of molecular pathways as a generic mechanism and as a core disease phenotype
R Ben-Hamo, S Efroni
Oncotarget 6 (3), 1594, 2015
Reactive animation
I Cohen, S Efroni, D Harel
US Patent App. 10/542,591, 2006
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
N Ben-Chetrit, D Chetrit, R Russell, C Koerner, M Mancini, A Abdul-Hai, ...
Science Signaling 8 (360), ra7-ra7, 2015
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer
H Cohen, R Ben-Hamo, M Gidoni, I Yitzhaki, R Kozol, A Zilberberg, ...
Breast Cancer Research 16, 1-16, 2014
The system can't perform the operation now. Try again later.
Articles 1–20